NASDAQ:HRTX

Heron Therapeutics Stock Predictions

etoro logo Buy HRTX
*Your capital is at risk
$0.447
-0.0032 (-0.711%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

HRTX Prediction Chart

HRTX Predictions History

Latest community submissions for HRTX.
Predictor Target Session Target Price Result Direction Accuracy Score
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Sep 10, 2020 $14.17 -3.08% $14.62 X 96.92% 1
JS JS Pro
Sep 10, 2020 $14.46 -1.09% $14.62 X 98.91% 2
iHustle84 iHustle84 Pro
Sep 10, 2020 $13.78 -5.75% $14.62 X 94.25% 1
Steve Talamantes Steve Talamantes @SteveTalamantes.172449
Sep 10, 2020 Bullish $14.62 X 0
Curtis Lauinger Curtis Lauinger @CurtisLauinger.172122
Sep 10, 2020 Bullish $14.62 X 0
Sep 10, 2020 Bearish $14.62 X 1
Sep 23, 2019 Bullish $19.39 X 0
JS JS Pro
Jul 22, 2019 $18.33 +0.83% $18.18 X 99.17% 2
CoffeeNtrees CoffeeNtrees @CoffeeNtrees.114765
Jul 22, 2019 $18.55 +2.04% $18.18 X 97.96% 0
Jul 22, 2019 $25.21 +38.67% $18.18 X 61.33% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for HRTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT HERON THERAPEUTICS
Heron Therapeutics
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acut...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE